MYRIAD GENETICS INC Quarterly Debt-to-equity in % from Q1 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Myriad Genetics Inc quarterly Debt-to-equity history and growth rate from Q1 2011 to Q2 2024.
  • Myriad Genetics Inc Debt-to-equity for the quarter ending June 30, 2024 was 51.4 %, a 24.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 51.4 +10 +24.2% Jun 30, 2024
Q1 2024 55.1 +21.5 +63.9% Mar 31, 2024
Q4 2023 53.2 +21.4 +67.3% Dec 31, 2023
Q3 2023 49.8 +17.7 +54.9% Sep 30, 2023
Q2 2023 41.3 +7.74 +23% Jun 30, 2023
Q1 2023 33.6 -5.53 -14.1% Mar 31, 2023
Q4 2022 31.8 -12.4 -28% Dec 31, 2022
Q3 2022 32.2 -18.1 -36.1% Sep 30, 2022
Q2 2022 33.6 -22.2 -39.8% Jun 30, 2022
Q1 2022 39.2 -17.2 -30.6% Mar 31, 2022
Q4 2021 44.2 -11.3 -20.4% Dec 31, 2021
Q3 2021 50.3 -1.4 -2.71% Sep 30, 2021
Q2 2021 55.9 +6.71 +13.7% Jun 30, 2021
Q1 2021 56.4 +9.56 +20.4% Mar 31, 2021
Q4 2020 55.5 +9.96 +21.9% Dec 31, 2020
Q3 2020 51.7 +6.26 +13.8% Sep 30, 2020
Q2 2020 49.1 +5.02 +11.4% Jun 30, 2020
Q1 2020 46.8 +7.72 +19.7% Mar 31, 2020
Q4 2019 45.5 +10.1 +28.7% Dec 31, 2019
Q3 2019 45.5 +13.3 +41.2% Sep 30, 2019
Q2 2019 44.1 +13 +41.7% Jun 30, 2019
Q1 2019 39.1 -0.37 -0.94% Mar 31, 2019
Q4 2018 35.4 -14.1 -28.5% Dec 31, 2018
Q3 2018 32.2 -27.5 -46.1% Sep 30, 2018
Q2 2018 31.1 -37.2 -54.5% Jun 30, 2018
Q1 2018 39.5 -19.1 -32.6% Mar 31, 2018
Q4 2017 49.5 +5.49 +12.5% Dec 31, 2017
Q3 2017 59.7 +30.9 +108% Sep 30, 2017
Q2 2017 68.3 +53.8 +370% Jun 30, 2017
Q1 2017 58.6 +44.6 +320% Mar 31, 2017
Q4 2016 44 +29.1 +195% Dec 31, 2016
Q3 2016 28.7 +13.9 +94% Sep 30, 2016
Q2 2016 14.5 -0.04 -0.28% Jun 30, 2016
Q1 2016 13.9 -0.35 -2.45% Mar 31, 2016
Q4 2015 14.9 +1.42 +10.5% Dec 31, 2015
Q3 2015 14.8 +1.51 +11.3% Sep 30, 2015
Q2 2015 14.6 +1.35 +10.2% Jun 30, 2015
Q1 2015 14.3 +2.17 +17.9% Mar 31, 2015
Q4 2014 13.5 +2.18 +19.3% Dec 31, 2014
Q3 2014 13.3 +2.88 +27.6% Sep 30, 2014
Q2 2014 13.2 +3.47 +35.6% Jun 30, 2014
Q1 2014 12.1 +2.8 +30% Mar 31, 2014
Q4 2013 11.3 +2.58 +29.6% Dec 31, 2013
Q3 2013 10.4 +2 +23.7% Sep 30, 2013
Q2 2013 9.75 +2.21 +29.3% Jun 30, 2013
Q1 2013 9.32 +2.02 +27.7% Mar 31, 2013
Q4 2012 8.71 +1.62 +22.9% Dec 31, 2012
Q3 2012 8.43 +1.7 +25.3% Sep 30, 2012
Q2 2012 7.54 +0.83 +12.4% Jun 30, 2012
Q1 2012 7.3 +0.92 +14.4% Mar 31, 2012
Q4 2011 7.09 Dec 31, 2011
Q3 2011 6.73 Sep 30, 2011
Q2 2011 6.71 Jun 30, 2011
Q1 2011 6.38 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.